期刊文献+

阿托品与盐酸戊乙奎醚对小鼠胃肠激素的影响

Comparison of the effect of penehyclidine hydrochloride and atropine on gastrointestinal hormone in mice
下载PDF
导出
摘要 目的比较阿托品与盐酸戊乙奎醚对小鼠胃肠激素的影响。方法健康昆明小鼠30只,体重18~24g,雌雄不拘,随机均分为三组后分别腹腔注射等容量等渗盐水(对照组,Ⅰ组)、阿托品0.3mg/kg组(Ⅱ组)、盐酸戊乙奎醚0.3mg/kg组(Ⅲ组)。三组给药30min后摘取眼球取血,处死小鼠,采用放免法测定血浆和胃肠组织中的胃动素和血管活性肠肽水平。结果Ⅱ组中小鼠血浆与组织中的血管活性肠肽水平明显高于Ⅰ、Ⅲ组(P<0.05),而胃动素水平则明显低于Ⅰ、Ⅲ组(P<0.05);Ⅰ、Ⅲ组差异无统计学意义。结论阿托品影响血管活性肠肽及胃动素的分泌,而盐酸戊乙奎醚则无影响。 Objective To compare the effect of penehyelidine hydrochloride and atropine on gastrointestinal hormone in mice. Methods Thirty healthy Kunming mice of both sexes weighing 18- 24 g were randomly divided into three groups(n= 10): group I received equi-volume normal saline, group Ⅱ received 0. 3 mg/kg of atropine intraperitoneally and group Ⅲ received 0. 3 mg/kg of penehyclidine hydrochloride intraperitoneally. The blood was collected at 30 min after the injection, and then sacrificed the animal for tissue collection. The contents of motilin and vasoactive intestinal peptide in plasma and gastrointestinal tissue were detected with: radioimmunoassay. Results Compared with group Ⅲ, the level of vasoactive intestinal peptide in both plasma and gastrointestinal tissue was significantly decreased in groups Ⅰ and Ⅲ, but the level of motilin was markedly increased (P 〈 0.05). No significant difference was observed in groups Ⅰ and m. Conclusion Atropine influences the excretion of vasoactive intestinal peptide and motilin, but penehyclidine hydrochloride not.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2012年第7期703-704,共2页 Journal of Clinical Anesthesiology
关键词 盐酸戊乙奎醚 血管活性肠肽 胃动素 阿托品 Penehyclidine hydroehloride Vasoactive intestinal peptide Motilin Atropine
  • 相关文献

参考文献10

  • 1董蜀华,朱涤非,郑永群.全麻术前静注盐酸戊乙奎醚的临床观察[J].临床麻醉学杂志,2009,25(10):879-880. 被引量:11
  • 2刘玉林,张琰,胡玉珍.主编.基础医学动物实验技术.西安:第四军医大学出版社,2008:115-116.
  • 3疏树华,潘建辉,王瑞明,方才.戊乙奎醚、东莨菪碱和阿托品用于老年患者术前用药的比较[J].临床麻醉学杂志,2009,25(12):1043-1045. 被引量:8
  • 4Borella LE, Lippmann W. A simple non-radioactive method for the simultaneous quantitative determination of stomach emptying and intestinal propulsion in the intact conscious rat. Digestion, 1980, 20(1) :36-49.
  • 5Moody TW, Chan D, Fahrenkruq J, et al. Neuropeptides as autocrine growth factors in cancer cells. Curr Pharm Des, 2003, 9(6): 495-509.
  • 6Nussdorfer GG, Malendowicz LK. Role of VIP, PACAP and related peptides in the regulation of the hypothalamo-pituita- ry-adrenal axis. Peptides, 1998, 19(8):1443-1467.
  • 7Grundy D, Schemann M. Enteric nervous system. Curr Opin Gastroenterol, 2006, 22(2): 102-110.
  • 8Brazer SIR, Borislow DS, Liddle RPu Chotecystokinin is not a maior hormonal regulator of lower esophageal sphincter pres- sure. Gastroenterology, 1990, 99(3) :641 645.
  • 9Depoortere I. Motilin and motilln receptors: characterization and functional significance. Verh K Acade Geneeskd Belg, 2001, 63(6) : 511-529.
  • 10McCallum RW. Clinical pharmacology forum: motility agents and the gastrointestinal tract. Am J Med Sci, 1996,312(1) : 19-26.

二级参考文献11

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部